NOVEMBER SALE - 20% OFF Everything!Shop Now
BPC-157 Capsules - 60 Capsules

BPC-157 Capsules

$52.00each · 60 Capsules

5.0· 3 reviewsout of 5In stock

Buy BPC-157 capsules for oral-route research, 60 per bottle. Every lot tested by independent labs with a public COA. Ships within 24 hours from the US.

Regular price $65.00Sale price $52.00You save $13.00 (20%)
1

Bundle & Save

Need more?

Select and SubscribeSave 20%
Order within 1h 17m to ship Fri, Nov 20Cutoff 5:00 PM PST · ships next business day
U.S. delivery availableFree shipping on orders over $150.00
Reship policyWrong item sent? We reship it free. Transit issues reviewed case by case.

Secure checkout · Visa · Mastercard · American Express · Discover · PayPal · Venmo · Apple Pay

Product details

BPC-157 Capsules, in brief. BPC-157 is a short chain of 15 amino acids, made in the lab and copied from part of a protein first described in gastric juice. In rat and cell studies it is studied for one job: helping injured tissue repair itself, mainly by helping blood vessels regrow and helping repair cells move into the damaged area [1,2]. What sets it apart from most peptides is that it has been tested by mouth. The research group that developed it describes it as stable in human gastric juice [3,4], and many of its rat studies gave it in drinking water as well as by injection [5,6,7,8,9]. In rats with a surgically created bladder fistula, every BPC-157 regimen, drinking water included, left the repaired bladder able to hold about five times more fluid before leaking than in controls [9]. What has never been measured is how much intact peptide reaches the blood after oral intake: the only published pharmacokinetic study found tested intravenous and intramuscular routes only [10]. NextGenPeps supplies BPC-157 Capsules in bottles of 60 capsules for laboratory use only.

What does BPC-157 do?

In animal studies it speeds up the repair of injured tissue, and in rats that effect has been reported when the peptide was simply dissolved in the drinking water. The same research group usually ran drinking-water groups side by side with injected groups, and in the studies below both routes were reported to work [5,6,7,8,9].

In practice the oral-route work covers three kinds of injury:

  • Gut and fistula models. In rats with a surgically made fistula from the colon to the skin, BPC-157 in drinking water or by injection healed the colon and skin defects and closed the fistula [5]; in a bladder fistula model it stopped leakage within a week of starting treatment [9].

  • Short bowel. After a large part of the small intestine was removed, untreated rats lost weight, while rats given BPC-157 in drinking water or by injection gained weight steadily above their pre-surgery values over four weeks [6].

  • Ligament and muscle-tendon injury. Oral BPC-157 improved healing of a cut knee ligament over 90 days [7] and restored function after the quadriceps muscle was detached from its tendon [8].

A 2025 systematic review of BPC-157 in muscle, tendon, ligament and bone found 36 eligible studies, 35 of them preclinical, so the evidence base is almost entirely animal and cell work [12].

NextGenPeps supplies BPC-157 Capsules for in vitro research and approved animal studies only. They are not sold as a drug, supplement or diagnostic.

How does BPC-157 work?

The short answer is that it makes blood vessel cells more responsive to growth signals and makes repair cells move. The route does not change the molecule, so this mechanism, worked out mostly in cultured cells, is the same one described on the BPC-157 vial page (Figure 1).

Blood vessels. In cultured endothelial cells, BPC-157 raised the amount of VEGFR2, the main receptor for the vessel growth factor VEGF, and switched on the VEGFR2, Akt and eNOS chain that produces nitric oxide. In rats with a blocked hind-limb artery it sped the recovery of blood flow [1].

Repair cells. In fibroblasts grown from rat Achilles tendon, BPC-157 did not make the cells divide faster. It increased how far they grew out of tendon explants, how many survived oxidative stress and how fast they migrated, through the FAK and paxillin pathway that cells use to crawl [2].

Diagram of two BPC-157 pathways: more VEGFR2 on endothelial cells leading to Akt and eNOS activation, nitric oxide and new vessels; and FAK and paxillin activation leading to cell spreading and tendon fibroblast migration.

Figure 1. How BPC-157 is thought to act. A simplified map of the two best-described pathways, from rat and cell studies with the peptide given by injection or added to cells; it is not a complete mechanism.[1,2]

Is BPC-157 stable in stomach acid?

It is described that way, but the claim rests on the developing group's own statements rather than a published stability dataset.

Reviews from the Zagreb group that first described BPC-157 call it stable in human gastric juice [3,11], and a 2014 book chapter by the same group states it was found to be stable for at least 24 hours in human gastric juice [4]. None of these sources presents the underlying experiment: the assay method, the pH, the temperature or the share of intact peptide left at each time point. The 2022 pharmacokinetic study repeats that BPC-157 resists gastric juice but did not test it [10].

Stability in gastric juice is also not the same as absorption. A peptide can survive the stomach and still be broken down in the gut wall or the liver before it reaches the circulation, and in rat plasma the injected peptide was broken into smaller fragments within minutes [10]. For oral-route experiments, stability under the actual study conditions is best checked directly, for example by HPLC of peptide incubated in simulated gastric fluid.

Does oral BPC-157 work? What animal studies show

In rats, yes: in every oral-route study reviewed for this page, drinking-water groups were reported to heal better than controls. Five studies show what that looked like.

Bladder fistulas closed and stopped leaking. Rats were given a fistula between the bladder and vagina and left untreated for 14 days, so the fistula was established before treatment began. They then received BPC-157 in drinking water or by injection, with plain water or saline as controls (6 rats per group per time point). All BPC-157 regimens stopped urine leakage through the vagina within the first week. Later in the study, the repaired bladder held about five times more fluid before leaking than in controls, and the fistula closed completely. Every control rat with a long-standing fistula developed a bladder stone; no BPC-157 rat did (Figure 2) [9].

Two-panel bar chart from a rat bladder fistula study: fluid held before leaking was about five times control with BPC-157, and bladder stones formed in all control rats against none of the BPC-157 rats; BPC-157 was given in drinking water or by injection.

Figure 2. Oral and injected BPC-157 in a rat bladder fistula model. Ratios and stone counts as stated in the paper's text, 6 rats per group per interval; drinking-water and injected regimens were reported together, not compared head to head. Source: Rasic et al., 2021.[9]

Colon fistulas healed. In rats with a fistula from the colon to the skin, BPC-157 given in drinking water or by injection accelerated healing of both the colon and skin defects over 28 days and closed the fistula, which then held more water without leaking. The anti-inflammatory drug sulphasalazine was only moderately effective, and a corticosteroid made healing worse [5].

Weight came back after bowel removal. After a large small-bowel resection, untreated rats lost weight. Rats given BPC-157 in drinking water or by injection gained weight steadily above their pre-surgery values over four weeks, with taller villi and deeper crypts in the remaining bowel, both signs of the gut adapting [6].

Ligaments and muscle-tendon junctions healed. After the medial collateral ligament of the knee was cut, BPC-157 given by injection, in drinking water or as a cream improved functional, biomechanical and microscopic healing over 90 days, and the authors state it was effective given orally [7]. After the quadriceps muscle was detached from its tendon, BPC-157 in drinking water or by injection was reported to give full functional recovery, less muscle wasting and smaller defects by day 42 [8].

Limits of this evidence. All five studies come from one research group, most abstracts report the direction of effects rather than group values, and none was designed to compare oral and injected routes statistically. A review from the same group on anti-inflammatory drug injury also describes both oral and injected regimens as protective [11].

BPC-157 Capsules vs injection: what differs between routes

In the rat literature the two routes gave similar healing results, but only the injected routes have blood-level data (Figure 3).

  • How it was given. Oral-route studies dissolved the peptide in drinking water, so the rats took it in through the day; injected studies gave a single daily intraperitoneal dose [5,6,7,8,9].

  • Healing outcomes. Where both routes were tested in the same study, both were reported to work, without a formal comparison of which worked better [5,6,7,8,9].

  • Blood levels. After intramuscular injection, bioavailability was about 14 to 19% in rats and 45 to 51% in dogs, and after intravenous dosing the intact peptide had a half-life of about 15 minutes in rats and about 5 minutes in dogs [10]. Oral bioavailability has not been reported.

  • Format. Capsules hold a fixed amount of dry material and need no reconstitution, while vials hold lyophilised powder that is dissolved before use. Gavage of a suspension or solution is the usual way to give a defined oral amount to a single animal.

Three-column comparison of BPC-157 routes: oral in drinking water used in rat fistula, short bowel, ligament and muscle-tendon studies with no blood-level data; intraperitoneal used in the same rat models with no blood-level data; intramuscular and intravenous with bioavailability of 14 to 19% in rats and 45 to 51% in dogs and half-lives of 15.2 and 5.27 minutes.

Figure 3. What is known for each route. Healing data come from rat studies that ran oral and intraperitoneal groups side by side; blood-level data come from a single rat and dog study of intravenous and intramuscular dosing. Sources: Klicek 2008, Sever 2009, Cerovecki 2010, Japjec 2021, Rasic 2021, He 2022.[5,6,7,8,9,10]

What is BPC-157 made of?

BPC-157 is a linear peptide of 15 amino acids, written GEPPPGKPADDAGLV (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val). The name stands for body protection compound 157, and the sequence is a partial sequence of a protein described in gastric juice. Its molecular formula is C62H98N16O22 and its molecular weight is 1419.5 g/mol (CAS 137525-51-0).

Four of the 15 residues are proline, three of them in a row near the start. In rats the peptide was broken down into small fragments and ultimately into single amino acids, and at one hour proline made up most of the radioactivity in plasma after a labelled dose [10]. The capsule contains the same sequence as the BPC-157 vials; only the format differs.

BPC-157 Capsules at a glance

  • Compound: BPC-157 (body protection compound 157), also written BPC 157

  • Class: Synthetic linear pentadecapeptide

  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)

  • Molecular weight: 1419.5 g/mol; formula C62H98N16O22; CAS 137525-51-0

  • Format: 60 capsules per bottle

  • Identity and purity: Every lot is tested by independent labs and the certificate of analysis is published in the NextGenPeps COA library

  • Appearance: Capsules in a sealed bottle

  • Reconstitution: Not required; the capsule fill can be dissolved or suspended for oral-route work

  • Half-life: Under 30 minutes in rats and dogs after intravenous or intramuscular dosing; not measured after oral dosing [10]

  • Regulatory status: Not an FDA-approved drug. Research use only

What are BPC-157 Capsules used to study?

Researchers use the oral format when the question is about the route itself, or about injuries of the gut where the peptide can act along the way.

  • Oral versus injected delivery. Head-to-head designs that test whether a drinking-water or gavage regimen reproduces an injected effect, ideally with plasma sampling, which the published work lacks [10].

  • Fistula healing. Colon-to-skin and bladder fistula models in rats, with leak volume, closure and histology as endpoints [5,9].

  • Intestinal adaptation. Short bowel models, with body weight, villus height and crypt depth as endpoints [6].

  • Ligament and muscle-tendon repair. Transected ligament and myotendinous junction models, with function and biomechanics as endpoints [7,8].

  • Gastric stability. Simulated gastric fluid assays that measure how much intact peptide remains over time [3,4].

Buying BPC-157 Capsules for research: what each bottle includes

Every lot is tested by independent labs and the certificate of analysis is published in the NextGenPeps COA library. For injected or in vitro work, the same peptide is available as BPC-157 in 5 mg and 10 mg vials, and BPC-157 / TB-500 Capsules pair it with a thymosin beta-4 fragment in the same oral format.

  • Lot documentation. The certificate of analysis for each lot is published in the COA library.

  • One format. 60 capsules per bottle.

  • US-based fulfilment. Orders ship within 24 hours from the United States, with free US shipping on orders over $150.

  • Research use only. BPC-157 Capsules are sold strictly for in vitro and approved animal research. They are not for human or veterinary use and are not sold as a drug, supplement or diagnostic.

BPC-157 Capsules handling, storage and analytical notes

Format. Supplied as capsules in a sealed bottle. No dosing instructions are supplied, and none should be taken from the studies above, which used peptide dissolved in drinking water or given by injection rather than capsules.

Storage. Keep the sealed bottle at 2 to 8 °C, dry and protected from light, and close it promptly after opening, since moisture degrades peptides. Material dissolved for an experiment should be held at 2 to 8 °C and used within the window the laboratory has validated.

Content. For quantitative work, confirm the peptide content of the capsule fill by HPLC against a reference standard rather than assuming a nominal amount, and report it in study records.

Short half-life. After injection the intact peptide had a half-life of 5 to 30 minutes depending on species, route and amount [10]. Any study measuring exposure after oral delivery needs early and frequent sampling and an assay that separates intact peptide from fragments.

Naming. BPC-157, BPC 157 and pentadecapeptide BPC 157 refer to the same sequence. PL 14736 is a development code used for the same peptide in some papers.

What is not established about BPC-157 Capsules

  • Oral bioavailability. No published study has measured how much intact BPC-157 reaches the blood after oral delivery in any species [10].

  • Gastric stability data. The stability claim comes from the developing group, and the underlying method and time-course data have not been published in full [3,4].

  • Capsule-specific data. The oral-route studies used peptide dissolved in drinking water. None tested a capsule format, and route comparisons were not powered to detect differences [5,6,7,8,9].

  • Independent replication. The oral-route healing studies come from a single research group, and no dedicated long-term safety study exists; a 2025 systematic review found no clinical safety data [12].


Research Use Only. The statements made within this website have not been evaluated by the US Food and Drug Administration. These materials are not intended to diagnose, treat, cure or prevent any disease and are not intended for human or veterinary use. Studies described on this page are reported for scientific context and are not guidance of any kind.

Published research

Compound information

Molecular class
Synthetic linear pentadecapeptide
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
Molecular formula
C₆₂H₉₈N₁₆O₂₂
Molecular weight
1419.5 g/mol
CAS number
137525-51-0
Format
60 capsules per bottle
Physical form
Capsules, sealed bottle
Purity
Every lot tested by independent labs; certificate of analysis published in the NextGenPeps COA library
Half-life
Under 30 minutes in rats and dogs (IV and IM); not measured after oral dosing
Oral bioavailability
Not reported in any published study
Regulatory status
Research use only. Not an FDA-approved drug

Storage & stability

  • Capsules in a sealed bottle
  • Store cold, dry and protected from light
  • Reseal promptly after opening
Sealed bottle
2 to 8 °C, dry, protected from light
Opened bottle
Close promptly; keep at 2 to 8 °C away from moisture
Dissolved material
2 to 8 °C, within a laboratory-validated window
Quantitation
Confirm peptide content of the fill by HPLC before quantitative work

Cited literature

  1. 01
    Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

    Hsieh MJ, Liu HT, Wang CN, et al. · J Mol Med 2017 · PubMed · DOI

    BPC 157 raised VEGFR2 (not VEGF-A), drove VEGFR2 internalisation and Akt-eNOS signalling, and sped blood-flow recovery in rat hind-limb ischemia. Injected or in vitro; the abstract gives no effect sizes.

  2. 02
    The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

    Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH · J Appl Physiol 2011 · PubMed · DOI

    In rat tendon fibroblasts, BPC 157 increased explant outgrowth, survival under oxidative stress and migration via FAK-paxillin, without changing proliferation. In vitro only.

  3. 03
    Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract

    Sikiric P, Seiwerth S, Rucman R, et al. · Curr Pharm Des 2011 · PubMed · DOI

    Review describing BPC 157 as stable in human gastric juice and summarising peroral and parenteral effects across gut injury models in rats. Written by the group that developed the peptide; gives no stability method or time-course data.

  4. 04
    Stable gastric pentadecapeptide BPC 157, somatosensory neurons and their protection and therapeutic extensions: a survey

    Sikiric P · InTech book chapter 2014 · DOI · Free full text

    Chapter in a book on capsaicin-sensitive afferent nerves stating that BPC 157 was found to be stable for at least 24 hours in human gastric juice and listing drinking water among the routes used. The stability statement carries no citation or data.

  5. 05
    Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system

    Klicek R, Sever M, Radic B, et al. · J Pharmacol Sci 2008 · DOI · Free full text

    BPC 157 given in drinking water or intraperitoneally healed colon and skin defects and closed colocutaneous fistulas in rats over 28 days; sulphasalazine was only moderately effective and a corticosteroid worsened healing. Abstract gives no closure rates or group sizes.

  6. 06
    Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats

    Sever M, Klicek R, Radic B, et al. · Dig Dis Sci 2009 · DOI

    After massive small bowel resection, rats given BPC 157 in drinking water or intraperitoneally gained weight above preoperative values over 4 weeks, with greater villus height and crypt depth. Abstract does not give body weight values.

  7. 07
    Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat

    Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P · J Orthop Res 2010 · PubMed · DOI

    BPC 157 given intraperitoneally, in drinking water or as a cream improved functional, biomechanical, macroscopic and histological healing of a transected medial collateral ligament over 90 days, and was stated to be effective per-orally. Abstract reports no group values.

  8. 08
    Stable gastric pentadecapeptide BPC 157 as a therapy for the disable myotendinous junctions in rats

    Japjec M, Horvat Pavlov K, Petrovic A, et al. · Biomedicines 2021 · DOI · Free full text

    After the quadriceps muscle was detached from its tendon, BPC 157 in drinking water or intraperitoneally gave functional recovery, less muscle atrophy and smaller defects through day 42 (6 rats per group per interval). Quantitative results are shown only in figures.

  9. 09
    Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats

    Rasic D, Zenko Sever A, Rasic F, et al. · Biomedicines 2021 · PubMed · DOI · Free full text

    All BPC 157 regimens, in drinking water or intraperitoneal, stopped leakage, allowed about five times more volume before leaking and prevented the bladder stones seen in all controls. Six rats per group per interval; routes were not compared statistically.

  10. 10
    Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs

    He L, Feng D, et al. · Front Pharmacol 2022 · PubMed · DOI · Free full text

    Half-life under 30 minutes and intramuscular bioavailability of 14 to 19% in rats and 45 to 51% in dogs; the peptide was broken down to amino acids. Only intravenous and intramuscular routes were tested, so oral bioavailability is not reported.

  11. 11
    Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157

    Drmic D, Sebecic B, Vrcic H, et al. · Curr Pharm Des 2013 · PubMed · DOI

    Review of rat studies in which peroral and parenteral BPC 157 counteracted gastrointestinal and other lesions caused by aspirin and other NSAIDs. Narrative review by the developing group, with no new data.

  12. 12
    Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review

    Vasireddi N, Hahamyan H, Salata MJ, et al. · HSS J 2025 · PubMed · DOI · Free full text

    36 studies: 35 preclinical and one 12-case clinical review. No acute toxicity in animals, no study beyond six weeks, and no clinical safety data. Heterogeneity prevented meta-analysis.

Frequently asked questions

How is BPC-157 Capsules packaged?

BPC-157 Capsules is supplied in the product format and quantity shown for the selected variant. Please inspect the sealed package when it arrives and contact support promptly if the package or labeling appears damaged.

How is BPC-157 Capsules shipped?

Orders are shipped within the United States via USPS. Transit times are typically 3–7 business days, depending on destination and carrier conditions. Tracking information is provided when available.

How should BPC-157 Capsules be stored?

Storage requirements are product-specific. Keep BPC-157 Capsules in its original labeled container and follow the product documentation or manufacturer instructions supplied with the order. Contact support if the applicable storage guidance is not available.

What is the refund policy for BPC-157 Capsules?

Due to the nature of research materials, NextGenPeps orders are final and are not eligible for refunds, returns, or exchanges. Review the shipping and reship policies before ordering.

Is BPC-157 Capsules intended for human use?

No. NextGenPeps materials are supplied strictly for laboratory research and development use and are not intended for human or animal consumption, clinical use, diagnostic use, cosmetic use, or dietary use.

Customer reviews

5.0out of 5 · 3 reviews

Reliable

Only vendor that have capsules in stock for this price. I buy it in bulk whenever I get low.

Bennett N.

Shipping is fast

Got my tracking info the same day and package 3 days later. Didn't expect it to come that quick with ground shipping

Brock B.

Never runs out

There are so many different options for BPC here , dont have to worry about shortages anytime soon.

Jeremy Q.

Common research questions

What are BPC-157 capsules?

BPC-157 capsules are an oral research format of BPC-157, a synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV, 1419.5 g/mol) taken from part of a protein described in gastric juice. The peptide is the same as in the injectable vials; only the format differs. In rats, BPC-157 dissolved in drinking water has been studied in fistula, short bowel, ligament and muscle-tendon injury models. NextGenPeps supplies the capsules for research use only.

Is BPC-157 stable in stomach acid?

The group that developed BPC-157 describes it as stable in human gastric juice, and a 2014 chapter by the same group states it was stable for at least 24 hours. The underlying experiment, including the method, pH and time-course data, has not been published in full, and the 2022 pharmacokinetic study repeats the claim without testing it. Surviving the stomach also does not show absorption, so oral-route studies should check stability under their own conditions.

Does oral BPC-157 work in animal studies?

In rats, BPC-157 given in drinking water was reported to work in every oral-route study reviewed here. It healed colon-to-skin and bladder fistulas, restored weight gain after small-bowel removal, and improved healing of a cut knee ligament and a detached muscle-tendon junction. In the bladder fistula study, all BPC-157 regimens let the bladder hold about five times more fluid before leaking than in controls. All of these studies come from one research group, and none measured blood levels.

What is the difference between BPC-157 capsules and injection in research?

The molecule is the same; the route differs. In rat studies that ran both routes side by side, drinking-water and intraperitoneal BPC-157 were both reported to work, without a statistical comparison between them. Blood-level data exist only for injected routes: intramuscular bioavailability was about 14 to 19% in rats and 45 to 51% in dogs, and the intravenous half-life was about 15 minutes in rats. Oral bioavailability has not been reported.

What is the oral bioavailability of BPC-157?

It has not been reported. The only published pharmacokinetic study of BPC-157, in rats and dogs in 2022, tested intravenous and intramuscular dosing only. In that study the injected peptide had a half-life under 30 minutes and was broken down into fragments and amino acids. Measuring oral exposure would need early, frequent sampling and an assay that separates intact peptide from fragments.

What does BPC-157 do?

In rat and cell studies BPC-157 speeds up repair of injured tissue. Cell work links this to more VEGFR2 signalling in blood vessel cells and FAK-paxillin driven migration of tendon fibroblasts. In rats it has improved healing of tendon, ligament, skin wounds and gut injuries, including when given in drinking water. The evidence is almost entirely preclinical.

Frequently Researched with

GHK-Cu

✓ 99.73% purity

GHK-Cu

$74.00$59.00

GLP-RT

✓ 99.72% purity

GLP-RT

$89.00$71.00

HCG

✓ 99.73% purity

HCG

$79.00$63.00

GLOW

✓ 99.71% purity

GLOW

$134.00$107.00

You have an unfinished subscription checkout

Continue your saved checkout, or replace its item with . Your saved selection and existing subscriptions will stay unchanged.

Continue saved checkout
NextGenPeps

Reliable and innovative research with our top-grade research materials and novel research compounds tailored to lead the competitive research industry. Choose research quality. Choose NextGenPeps.

Customer Service: +1 (971) 300-1435

Get 10% Off Your First Order

Sign up now and receive a 10% discount code valid on your next purchase!

Nextgenpeps LLC

The statements made within this website have not been evaluated by the US Food and Drug Administration. The materials offered by this company are not intended to diagnose, treat, cure, or prevent any disease. All research materials on this site are for laboratory research and development use only, and are not intended for human use.

NextGenPeps is a chemical supplier. NextGenPeps is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. NextGenPeps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

Privacy PolicyTerms & ConditionsAffiliate Program

501 W Broadway Ste A, San Diego, CA 92101

© 2026 NextGenPeps. All rights reserved.

Visa
American Express
Mastercard
PayPal
Discover
Apple Pay